Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001568344 | SCV003835484 | pathogenic | Aicardi-Goutieres syndrome 9 | 2022-09-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003223725 | SCV003919532 | likely pathogenic | not provided | 2022-10-26 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect with severely reduced processing efficiency (Kolev and Steitz, 2006); This variant is associated with the following publications: (PMID: 33230297, 16547514) |
Mayo Clinic Laboratories, |
RCV003223725 | SCV005414062 | likely pathogenic | not provided | 2024-05-30 | criteria provided, single submitter | clinical testing | PP4, PM1, PM3, PS3_supporting |
OMIM | RCV001568344 | SCV001792200 | pathogenic | Aicardi-Goutieres syndrome 9 | 2021-08-16 | no assertion criteria provided | literature only | |
Undiagnosed Diseases Network, |
RCV001568344 | SCV002818556 | pathogenic | Aicardi-Goutieres syndrome 9 | 2022-09-06 | no assertion criteria provided | clinical testing |